You are here:

  1. Home
  2. NICE Guidance
  3. NICE Advice
  4. Medtech innovation briefings

Helge for detecting haemolysis

  • Medtech innovation briefing
  • Reference number: MIB225
  • Published:  01 September 2020

Download (PDF)
  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Expert comments
  • Expert commentators
  • Development of this briefing

Regulatory information

Helge is a CE-marked class I (In Vitro Diagnostic Directive general category, or In Vitro Diagnostic Regulation class A) medical device.


Next page Equality considerations Previous page The technology
Back to top